PUBLIC RELEASE DATE: <\/p>\n
8-May-2014 <\/p>\n
Contact: Vicki Cohn vcohn@liebertpub.com<\/a> 914-740-2156 Mary Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n New Rochelle, NY, May 8, 2014The powerful anti-inflammatory compound interleukin-10 (IL-10) plays a crucial role in regenerative, scarless healing of fetal skin. Studies of IL-10 in postnatal skin wounds have demonstrated its promise as an anti-scarring therapeutic agent, as described in a Critical Review article published in Advances in Wound Care, a monthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers and an Official Journal of the Wound Healing Society. The article is available free on the Advances in Wound Care website. <\/p>\n In \"Regenerative Wound Healing: The Role of Interleukin-10,\" Sundeep Keswani and co-authors, Cincinnati Children's Hospital Medical Center (OH), and Children's Hospital Colorado and the University of Colorado School of Medicine, Aurora, review the complex processes, cell types, growth factors, and other agents needed for successful wound healing. The authors explore the ability of fetal skin to heal without scars and describe the results of ongoing studies to develop IL-10 as an anti-scarring agent. <\/p>\n \"Regenerative healing in adults is approachable through lessons learnt from fetal wounds,\" says Editor-in-Chief Chandan K. Sen, PhD, Professor of Surgery and Director of the Comprehensive Wound Center and the Center for Regenerative Medicine and Cell-Based Therapies at The Ohio State University Wexner Medical Center, Columbus, OH. <\/p>\n ### <\/p>\n About the Journal <\/p>\n Advances in Wound Care is a monthly peer-reviewed journal published online and in print that reports the latest scientific discoveries, translational research, and clinical developments in acute and chronic wound care. Each issue provides a digest of the latest research findings, innovative wound care strategies, industry product pipeline, and developments in biomaterials and skin and tissue regeneration to optimize patient outcomes. The broad scope of applications covered includes limb salvage, chronic ulcers, burns, trauma, blast injuries, surgical repair, skin bioengineering, dressings, anti-scar strategies, diabetic ulcers, ostomy, bedsores, biofilms, and military wound care. Complete tables of content and a sample issue may be viewed on the Advances in Wound Care website. <\/p>\n About the Publisher <\/p>\n <\/p>\n Read more from the original source: <\/p>\n Promising role for interleukin-10 in scarless wound healing<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" PUBLIC RELEASE DATE: 8-May-2014 Contact: Vicki Cohn vcohn@liebertpub.com<\/a> 914-740-2156 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, May 8, 2014The powerful anti-inflammatory compound interleukin-10 (IL-10) plays a crucial role in regenerative, scarless healing of fetal skin. Studies of IL-10 in postnatal skin wounds have demonstrated its promise as an anti-scarring therapeutic agent, as described in a Critical Review article published in Advances in Wound Care, a monthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers and an Official Journal of the Wound Healing Society. The article is available free on the Advances in Wound Care website Continue reading